Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKesson
Daiichi Sankyo
Baxter
Chubb
Covington
Fish and Richardson
McKinsey
Healthtrust

Generated: May 21, 2018

DrugPatentWatch Database Preview

CELLCEPT Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cellcept, and when can generic versions of Cellcept launch?

Cellcept is a drug marketed by Roche Palo and is included in four NDAs.

The generic ingredient in CELLCEPT is mycophenolate mofetil hydrochloride. There are thirty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the mycophenolate mofetil hydrochloride profile page.
Drug patent expirations by year for CELLCEPT
Pharmacology for CELLCEPT
Synonyms for CELLCEPT
(4E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-4-HEXENOIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER
(4E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)4-HEXENOIC ACID 4-METHYL-2-(4-MORPHOLINYL)ETHYL ESTER
(E)-2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate
(E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid 2-(4-Morpholinyl)ethyl Ester
(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester
007M346
115007-34-6
128794-94-5
140401-05-4
2-(4-Morpholinyl)ethyl (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(6-methoxy-7-methyl-4-oxidanyl-3-oxidanylidene-1H-2-benzofuran-5-yl)-4-methyl-hex-4-enoate
2-morpholin-4-ylethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate
2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
4-HEXENOIC ACID, 6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-, 2-(4-MORPHOLINYL)ETHYL ESTER
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (E)-
4-Hexenoic acid,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
4-HEXENOIC ACID,6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-,2-(4-MORPHOLINYL)ETHYL ESTER, (4E)-
6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester
6-[(7-Hydroxy-5-methoxy-4-methyl-1-oxo-3H-isobenzofuran-6-yl)]-4-methyl-hex-4-enoic acid 2-morpholinoethyl ester
6-[(7-hydroxy-5-methoxy-4-methyl-1-oxo-3h-isobenzofuran-6-yl)]-4-methyl-hex-4-enoicacid2-morpholinoethylester
9242ECW6R0
A803280
A805863
AB0125583
AB01274794_03
AB01274794_04
AB01274794-01
AB01274794-02
AB07560
ABP000539
AC-1562
AC1NQXZW
AC1Q6O6X
ACT01993
AJ-78121
AK-98658
AKOS005720900
ALBB-027273
AN-14797
AN-33289
AOB5505
BB_NC-2566
BBL029073
BC225627
BC283431
BCP9000969
C07908
C23H31NO7
CAS-128794-94-5
CCG-213315
Cellcept (TN)
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
CHEBI:8764
CHEBI:93612
CHEMBL1456
CS-2135
D00752
D04FBR
D0MS5I
DB00688
DR002683
DSSTox_CID_3340
DSSTox_GSID_23340
DSSTox_RID_76982
DTXSID3023340
GTPL6831
HE183403
HE183404
HMS2090A03
HSDB 7436
HY-B0199
I01-0898
I06-1947
J-005626
J90063
KS-1209
Linfonex
LS-172272
LS-75572
M2387
ME-MPA
MFCD00867568
MLS003915627
MLS004774133
MLS006011929
MMF CellCept(TM)
Mofetil mycophenolate
MolPort-000-883-800
morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
Morpholinoethyl E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
Morpholinoethyl E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
Munoloc
myclausen
mycophenolate mofetil
Mycophenolate mofetil (CellCept)
Mycophenolate mofetil (JAN/USAN)
Mycophenolate mofetil [USAN:USP]
Mycophenolate mofetil for peak identification, European Pharmacopoeia (EP) Reference Standard
Mycophenolate mofetil Teva
Mycophenolate mofetil, >=98% (HPLC)
Mycophenolate mofetil, European Pharmacopoeia (EP) Reference Standard
Mycophenolate Mofetil, pharmaceutical secondary standard; traceable to USP, PhEur
Mycophenolate mofetil, United States Pharmacopeia (USP) Reference Standard
Mycophenolate mofetil(CellCept)/
Mycophenolatemofetil
Mycophenolatmofetil
MYCOPHENOLIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
Myfenax
NCGC00159459-02
NCGC00159459-03
NCGC00159459-04
NSC-724229
NSC-758905
NSC724229
NSC758905
Pharmakon1600-01504567
Q-101316
R-99
R-99 (immune disorders), Asterand
R-99 (immune disorders), Pharmagene
R-99 (inflammation), Pharmagene
R-99 (ocular disease), Allergan
R3925
RS 61443
RS-61443
RS-61443-190
RTGDFNSFWBGLEC-SYZQJQIISA-N
s1501
SC-19049
SCHEMBL218782
SCHEMBL4195
SMR002544686
SMR004703518
SR-05000001485
SR-05000001485-2
ST24035026
STL146382
TL8000648
TM-MMF
Tox21_111686
Tox21_111686_1
UNII-9242ECW6R0
ZINC21297660

US Patents and Regulatory Information for CELLCEPT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo CELLCEPT mycophenolate mofetil CAPSULE;ORAL 050722-001 May 3, 1995 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Roche Palo CELLCEPT mycophenolate mofetil TABLET;ORAL 050723-001 Jun 19, 1997 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Roche Palo CELLCEPT mycophenolate mofetil hydrochloride INJECTABLE;INJECTION 050758-001 Aug 12, 1998 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Roche Palo CELLCEPT mycophenolate mofetil SUSPENSION;ORAL 050759-001 Oct 1, 1998 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for CELLCEPT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo CELLCEPT mycophenolate mofetil hydrochloride INJECTABLE;INJECTION 050758-001 Aug 12, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Roche Palo CELLCEPT mycophenolate mofetil CAPSULE;ORAL 050722-001 May 3, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Roche Palo CELLCEPT mycophenolate mofetil TABLET;ORAL 050723-001 Jun 19, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Roche Palo CELLCEPT mycophenolate mofetil SUSPENSION;ORAL 050759-001 Oct 1, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for CELLCEPT
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe For Oral Suspension 200 mg/mL ➤ Subscribe 2011-03-25

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
McKesson
Chubb
Cerilliant
Chinese Patent Office
Teva
Merck
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.